Medical Innovation Exchange

CureVac rethinks lead cancer program after posting PD-1 data, limiting future studies to mRNA vaccine combos

https://www.fiercebiotech.com/biotech/curevac-rethinks-lead-cancer-program-after-posting-pd-1-data-limiting-future-studies-mrna

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!